JW
Jeffrey W Sherman bought $10K of LRMR stock
Jeffrey W Sherman, Dir of Larimar Therapeutics, Inc. (LRMR), bought 3,289 shares of LRMR stock worth $10K, per an SEC Form 4 filed Nov 16, 2026.
It was an open-market purchase.
The trade was reported on Nov 16, 2026.
LRMR has moved +7.3% since the trade date, from $3.00 to $3.22 (Nov 19, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 0 days
- Price since
- +7.3%
- Role
- Dir
- Source
- SEC Form 4